Six Key ETFs to Monitor as Wall Street Enters Its Strongest Six-Month Period
Halloween Effect in Investing: The Halloween Effect suggests that stocks tend to outperform from November to April, with historical data showing average returns of 5.2% during this period compared to 2.6% from May to October.
ETFs for Seasonal Gains: Investors are looking at specific ETFs to capitalize on the upcoming seasonal rally, particularly in healthcare, financials, and semiconductor sectors, which are expected to perform well.
Healthcare ETFs: The Health Care Select Sector SPDR ETF (XLV) and SPDR S&P Biotech ETF (XBI) are gaining traction, with XLV up over 4% and XBI over 12% in the past month, making them attractive defensive investments.
Financial and Semiconductor ETFs: The iShares U.S. Financials ETF (IYF) and iShares U.S. Financial Services ETF (IYG) are positioned for a rebound, while the VanEck Semiconductor ETFs (SMH and SMHX) are benefiting from strong demand in AI and data centers.
Trade with 70% Backtested Accuracy
Analyst Views on JPM
About JPM
About the author

- Significant Investment Returns: Over the past decade, JPMorgan Chase has achieved a total return of 497%, significantly outperforming the S&P 500's 328%, indicating that a $10,000 investment made ten years ago would now be worth approximately $59,680, showcasing its strong performance in the financial services sector.
- Robust Revenue Growth: The company is projected to experience a compound annual revenue growth rate of 6.9% from 2015 to 2025, with net income expected to rise at an annual rate of 8.9%, reflecting strong performance across all business segments and enhancing its market position.
- Challenges from Economic Environment: Despite facing a complex macroeconomic backdrop including the COVID-19 pandemic, rising inflation, increasing interest rates, and geopolitical tensions, JPMorgan Chase has continued to thrive, demonstrating the resilience and adaptability of its business model.
- Profitability Advantage: With a net profit margin of 33.1% in Q1 2023, JPMorgan Chase showcases its competitive edge in the industry, while analysts anticipate an annual earnings growth rate of 9.6% from 2025 to 2028, further solidifying investor confidence in the company's future performance.
- Strong Performance in Financial Stocks: Financial stocks showed a broad increase in late Thursday trading, reflecting a gradual recovery in market confidence towards the financial sector, which may boost investor sentiment.
- NYSE Financial Index Up: The NYSE Financial Index rose during trading, indicating that financial stocks are performing better than market expectations, potentially attracting more capital into this sector.
- Improved Market Sentiment: The rise in financial stocks may be linked to improving economic data and changing interest rate expectations, as investors gain confidence in future economic recovery, thereby driving stock prices higher.
- Increased Investor Attention: With the rise in financial stocks, investor attention towards the sector has increased, which could lead to more capital inflows into the financial markets, further propelling stock prices upward.
- Strong IPO Performance: Quantinuum opened at $68 per share on Nasdaq, raising $1.68 billion and achieving a market cap of approximately $17.6 billion, reflecting robust market interest and confidence in quantum computing.
- Diverse Customer Base: The company serves clients across pharmaceuticals, materials science, and finance, including JPMorgan Chase and Amgen, indicating significant application potential for its quantum computing platform and reinforcing its market position.
- Enhanced Funding Support: The U.S. Department of Commerce announced a $100 million funding commitment to Quantinuum, recognizing its strategic asset status within the quantum ecosystem, which will aid in accelerating technology development and market expansion.
- Financial Challenges: Despite a successful IPO, the company reported a 73% year-over-year revenue decline to $5.24 million in Q1, with a net loss of $136.5 million, highlighting financial pressures and challenges amid rapid expansion.
- Decade-Long Returns: As of June 3, JPMorgan Chase has achieved a total return of 497% over the past ten years, significantly outperforming the S&P 500's 328%, underscoring its leadership and appeal in the financial services sector.
- Asset Scale and Market Cap: With total assets under management of $4.9 trillion and a market capitalization of $795 billion, JPMorgan Chase's robust financial foundation instills confidence among investors as a critical component of the economy.
- Earnings Growth Potential: Analysts project that JPMorgan Chase's earnings per share will grow at an annualized rate of 9.6% from 2025 to 2028, indicating strong profitability even amid challenging macroeconomic conditions.
- Valuation and Market Positioning: Although JPMorgan Chase trades at a price-to-book ratio of 2.3, reflecting a premium valuation, its strong economic moat and a net profit margin of 33.1% make it a compelling choice for investors seeking quality banking exposure.
- Impact of Quantitative Tightening: New Fed Chair Kevin Warsh's proposal to shrink the $6.7 trillion balance sheet is expected to implement quantitative tightening through bond sales or maturities, thereby reducing liquidity in financial markets and potentially raising interest rates, which will influence investor decisions.
- Opportunities for Berkshire Hathaway: As of March 31, 2026, Berkshire Hathaway holds over $397 billion in cash and short-term investments, the highest in its history, and if rates rise, it will increase interest income, allowing the company to leverage its cash reserves to acquire quality stocks at lower prices.
- Growth Potential for JPMorgan Chase: JPMorgan Chase anticipates generating $103 billion in interest income this year, and if interest rates rise, its net interest income will likely grow further, potentially attracting customers from smaller banks under competitive pressures, enhancing its market position.
- Advantages for UnitedHealth Group: As the largest health insurer, UnitedHealth Group can benefit from higher interest rates on its float, and despite potential consumer spending cuts, its valuation remains about 40% below its 2024 peak, making it more attractive to investors if Warsh successfully reduces the Fed's balance sheet.
- Vanguard's Investment Philosophy: Founded by John Bogle in 1975, Vanguard pioneered a low-fee, investor-friendly approach that democratized access to index funds, significantly lowering investment barriers and influencing the broader investment landscape.
- International Stock ETF Performance: The Vanguard Total International Stock Index Fund ETF (VXUS) holds 8,770 stocks and achieved a 33.04% annualized return over the past year, with a minimal expense ratio of 0.05% and a dividend yield of 2.7%, making it an ideal choice for navigating potential U.S. economic slowdowns.
- Tech Sector ETF Advantages: The Vanguard Information Technology Index Fund ETF (VGT) focuses on U.S. tech companies, boasting a remarkable 64.55% annualized return over the past year; despite a low dividend yield of 0.3%, its strong growth potential attracts investors, particularly in fast-growing sectors like AI and cloud computing.
- Stability of Value ETFs: The Vanguard Mega Cap Value Index Fund ETF (MGV) targets undervalued large-cap companies, delivering a 26.63% annualized return over the past year, with a low expense ratio of 0.05% and a 1.9% dividend yield, providing a margin of safety for risk-averse investors during market downturns.











